QA: Bioxytran INC in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001445815_2014_Bioxytran_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001445815, Bioxytran INC

  xvar xval
0 AssetsCurrent 93,131
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 165,306
3 remainder_Assets 0
4 LiabilitiesCurrent 182,989
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 2,389,816
11 remainder_Revenues 417,336
12 remainder_NetIncome 193,944
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 258,437
1 Liabilities 182,989
2 Expenses 2,389,816
3 Revenues 417,336
4 StockholdersEquity 75,448
5 NetIncome -1,778,536
6 ComprehensiveNetIncome -1,778,536
7 BaseVar 1,721,261
8 EconomicCapitalRatiobeforeLimitedLiability -7.31
9 EconomicCapitalRatio 0.0196

Edgar->Model Mapping

Feature Distribution

Change over Time